Clonal Spread of Carbapenem Non-susceptible Acinetobacter baumannii in an Intensive Care Unit in a Teaching Hospital in China
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: This study was aimed to investigate the genetic diversity and antibiotic resistance profile of the nosocomial infection agent Acinetobacter baumannii from a medical intensive care unit (ICU) in a teaching hospital in Suzhou, China. Methods: The genetic relationship among A. baumannii isolates in an ICU was investigated using multilocus sequence typing (MLST). The antibiotic resistance pattern was determined by performing an antibiotic susceptible test, which included an agar dilution method and an E-test method. Resistant determinants, e.g., carbapenemase genes, metallo-β- lactamases, and class 1 integron, were analyzed by specific PCR and DNA sequencing. Results: In the present study, 33 non-duplicate isolates were identified as 5 existing sequence types (STs) (ST92, ST75, ST112, ST145, and ST345) and 1 new sequence type STn, which has a G-A mutation at nt268 on ropD40 of ST251. These results reveal limited diversity in carbapenem non-susceptible A. baumannii (CNSAb) isolates in our ICU, which are comprised of only 2 distinct STs, with ST92 and ST75 clustering into a clonal complex (CC) 92. Most CNSAb isolates (94.4%, 17/18) harbored the OXA-23 gene, while no carbapenem-susceptible A. baumannii (CSAb) isolates harbored it. In addition, 66.7% (22/33) isolates were positive for class 1 integrase, and gene cassette analysis showed there are 3 gene arrays among them, i.e., aacA4-catB8-aadA1 (77.3%, 17/22), aacA4 (22.7%, 5/22), and aacC1-orfX-orfX’-aadA1 (4.5%, 1/22). Conclusions: When all these data are combined, the antibiotic resistance and wide distribution of CNSAb isolates in our ICU are probably caused by expansion of the CC92 clone.
Abstract
Background: This study was aimed to investigate the genetic diversity and antibiotic resistance profile of the nosocomial infection agent Acinetobacter baumannii from a medical intensive care unit (ICU) in a teaching hospital in Suzhou, China. Methods: The genetic relationship among A. baumannii isolates in an ICU was investigated using multilocus sequence typing (MLST). The antibiotic resistance pattern was determined by performing an antibiotic susceptible test, which included an agar dilution method and an E-test method. Resistant determinants, e.g., carbapenemase genes, metallo-β- lactamases, and class 1 integron, were analyzed by specific PCR and DNA sequencing. Results: In the present study, 33 non-duplicate isolates were identified as 5 existing sequence types (STs) (ST92, ST75, ST112, ST145, and ST345) and 1 new sequence type STn, which has a G-A mutation at nt268 on ropD40 of ST251. These results reveal limited diversity in carbapenem non-susceptible A. baumannii (CNSAb) isolates in our ICU, which are comprised of only 2 distinct STs, with ST92 and ST75 clustering into a clonal complex (CC) 92. Most CNSAb isolates (94.4%, 17/18) harbored the OXA-23 gene, while no carbapenem-susceptible A. baumannii (CSAb) isolates harbored it. In addition, 66.7% (22/33) isolates were positive for class 1 integrase, and gene cassette analysis showed there are 3 gene arrays among them, i.e., aacA4-catB8-aadA1 (77.3%, 17/22), aacA4 (22.7%, 5/22), and aacC1-orfX-orfX’-aadA1 (4.5%, 1/22). Conclusions: When all these data are combined, the antibiotic resistance and wide distribution of CNSAb isolates in our ICU are probably caused by expansion of the CC92 clone.
참고문헌 (35)
- Joly-Guillou ML, "Clinical impact and pathogenicity of Acinetobacter", Clin Microbiol Infect, 11, pp.868~873 (2005)
- Abbo A, "Multidrug-resistant Acinetobacter baumannii", Emerg Infect Dis, 11, pp.22~29 (2005)
- Piazza O, "Incidence of antimicrobial-resistant ventilator associated pneumonia: an eighteen-month survey", Panminerva Med, 47, pp.265~267 (2005)
- Wu CJ, "Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003", J Microbiol Immunol Infect, 39, pp.135~143 (2006)
- Jeon BC, "Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea", JOURNAL OF CLINICAL MICROBIOLOGY, 43, pp.2241~2245 (2005), AMER SOC MICROBIOLOGY
- Lee K, "Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea", Antimicrob Agents Chemother, 49, pp.4485~4491 (2005)
- Poirel L, "OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii", Antimicrob Agents Chemother, 49, pp.202~208 (2005)
- Turton JF, "The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii", FEMS Microbiol Lett, 258, pp.72~77 (2006)
- Brown S, "Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina", Clin Microbiol Infect, 11, pp.15~23 (2005)
- Merkier AK, "Bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii", Int J Antimicrob Agents, 28, pp.110~113 (2006)
- Zhou H, "Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital", J Med Microbiol, 56, pp.1076~1080 (2007)
- White PA, "Integrons and gene cassettes in the enterobacteriaceae", Antimicrob Agents Chemother, 45, pp.2658~2661 (2001)
- Gu B, "Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China", J Clin Microbiol, 45, pp.241~243 (2007)
- Fu Y, "Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China", J Antimicrob Chemother, 65, pp.644~650 (2010)
- He C, "Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit", J Med Microbiol, 60, pp.337~341 (2011)
- Adams-Haduch JM, "Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States", J Clin Microbiol, 49, pp.3849~3854 (2011)
- Chang HC, "Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region", J Clin Microbiol, 43, pp.1632~1639 (2005)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals, 3rd ed", Clinical and Laboratory Standards Institute, ~ (2008)
- Lee K, "Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp", J Clin Microbiol, 41, pp.4623~4629 (2003)
- Bartual SG, "Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii", J Clin Microbiol, 43, pp.4382~4390 (2005)
- Feil EJ, "eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data", J Bacteriol, 186, pp.1518~1530 (2004)
- Wang F, "CHINET 2007 surveillance of bacterial resistance in China", Chinese Journal of Infection and Chemotherapy (Chinese), 8, pp.325~334 (2008)
- Zhang L, "Mohnarin annual report 2010:surveillance of antimicrobial resistance in bacteria isolated from intensive care units", Chinese Journal of Nosocomiology, 28, pp.330~335 (2012)
- Zhang JP, "Molecular epidemiological study of multi-drug resistant Acinetobacter baumannii (Chinese)", Zhonghua Nei Ke Za Zhi, 49, pp.657~661 (2010)
- Grosso F, "OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro?", J Antimicrob Chemother, 66, pp.62~65 (2011)
- Wang H, "Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals", Antimicrob Agents Chemother, 51, pp.4022~4028 (2007)
- Lei J, "Study of metallo-β-lactamase of Carbapenems-resistant Acinetobacter baumanii", Modern Journal of Integrated Traditional Chinese and Western Medicine, 27, pp.3280~3281 (2009)
- Dawes FE, "Distribution of class 1 integrons with IS26-mediated deletions in their 3’-conserved segments in Escherichia coli of human and animal origin", PLoS One, 5, pp.e12754~ (2010)
- Moura A, "INTEGRALL: a database and search engine for integrons, integrases and gene cassettes", Bioinformatics, 25, pp.1096~1098 (2009)
- Xu X, "Integron gene cassettes in Acinetobacter spp. strains from South China", Int J Antimicrob Agents, 32, pp.441~445 (2008)
- Hornsey M, "Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy", J Antimicrob Chemother, 66, pp.1499~1503 (2011)
- Fournier PE, "Comparative genomics of multidrug resistance in Acinetobacter baumannii", PLoS Genet, 2, pp.e7~ (2006)
- Zhou H, "Genomic analysis of the multidrug-resistant Acinetobacter baumannii strain MDR-ZJ06 widely spread in China", Antimicrob Agents Chemother, 55, pp.4506~4512 (2011)
- Krizova L, "Diversity and evolution of AbaR genomic resistance islands in Acinetobacter baumannii strains of European clone I", Antimicrob Agents Chemother, 55, pp.3201~3206 (2011)
- Ruiz-Martinez L, "Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa", Int J Antimicrob Agents, 35, pp.398~402 (2011)
